Carbapenem Resistance, Initial Antibiotic Therapy, and Mortality in Klebsiella pneumoniae Bacteremia: A Systematic Review and Meta-Analysis

被引:73
作者
Kohler, Philipp P. [1 ,2 ,3 ]
Volling, Cheryl [1 ]
Green, Karen [1 ]
Uleryk, Elizabeth M. [1 ,4 ]
Shah, Prakesh S. [1 ,2 ]
McGeer, Allison [1 ,2 ]
机构
[1] Mt Sinai Hosp, Toronto, ON, Canada
[2] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
[3] Cantonal Hosp St Gallen, Clin Infect Dis & Hosp Epidemiol, Rorschacher Str 95, CH-9007 St Gallen, Switzerland
[4] EM Uleryk Consulting, Mississauga, ON, Canada
基金
瑞士国家科学基金会;
关键词
BLOOD-STREAM INFECTIONS; MULTIDRUG-RESISTANT; BETA-LACTAMASE; K.-PNEUMONIAE; RISK-FACTORS; IMPACT; EPIDEMIOLOGY; OUTCOMES; PREDICTORS; SPREAD;
D O I
10.1017/ice.2017.197
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BACKGROUND Mortality associated with infections caused by carbapenem-resistant Enterobacteriaceae (CRE) is higher than mortality due to carbapenem-sensitive pathogens. OBJECTIVE To examine the association between mortality from bacteremia caused by carbapenem-resistant (CRKP) and carbapenem-sensitive Klebsiella pneumoniae (CSKP) and to assess the impact of appropriate initial antibiotic therapy (IAT) on mortality. DESIGN Systematic review and meta-analysis METHODS We searched MEDLINE, EMBASE, CINAHL, and Wiley Cochrane databases through August 31, 2016, for observational studies reporting mortality among adult patients with CRKP and CSKP bacteremia. Search terms were related to Klebsiella, carbapenem-resistance, and infection. Studies including fewer than 10 patients per group were excluded. A random-effects model and meta-regression were used to assess the relationship between carbapenem-resistance, appropriateness of IAT, and mortality. RESULTS Mortality was higher in patients who had CRKP bacteremia than in patients with CSKP bacteremia (15 studies; 1,019 CRKP and 1,148 CSKP patients; unadjusted odds ratio [OR], 2.2; 95% confidence interval [CI], 1.8-2.6; I-2=0). Mortality was lower in patients with appropriate IAT than in those without appropriate IAT (7 studies; 658 patients; unadjusted OR, 0.5; 95% CI, 0.3-0.8; I-2=36%). CRKP patients (11 studies; 1,326 patients; 8-year period) were consistently less likely to receive appropriate IAT (unadjusted OR, 0.5; 95% CI, 0.3-0.7; I-2=43%). Our meta-regression analysis identified a significant association between the difference in appropriate IAT and mortality (OR per 10% difference in IAT, 1.3; 95% CI, 1.0-1.6). CONCLUSIONS Appropriateness of IAT is an important contributor to the observed difference in mortality between patients with CRKP bacteremia and patients with CSKP bacteremia. Infect Control Hosp Epidemiol 2017;38:1319-1328
引用
收藏
页码:1319 / 1328
页数:10
相关论文
共 40 条
[1]   Trends in the annual incidence of carbapenem-resistant Klebsiella pneumoniae bloodstream infections: a 8-year retrospective study in a large teaching hospital in northern Italy [J].
Alicino, Cristiano ;
Giacobbe, Daniele Roberto ;
Orsi, Andrea ;
Tassinari, Federico ;
Trucchi, Cecilia ;
Sarteschi, Giovanni ;
Copello, Francesco ;
Del Bono, Valerio ;
Viscoli, Claudio ;
Icardi, Giancarlo .
BMC INFECTIOUS DISEASES, 2015, 15
[2]  
[Anonymous], IDWEEK 2016
[3]  
[Anonymous], HEALTHC ASS INF DIS
[4]   Epidemiology and outcomes of bloodstream infection in patients with cirrhosis [J].
Bartoletti, Michele ;
Giannella, Maddalena ;
Caraceni, Paolo ;
Domenicali, Marco ;
Ambretti, Simone ;
Tedeschi, Sara ;
Verucchi, Gabriella ;
Badia, Lorenzo ;
Lewis, Russell E. ;
Bernardi, Mauro ;
Viale, Pierluigi .
JOURNAL OF HEPATOLOGY, 2014, 61 (01) :51-58
[5]   Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections [J].
Ben-David, D. ;
Kordevani, R. ;
Keller, N. ;
Tal, I. ;
Marzel, A. ;
Gal-Mor, O. ;
Maor, Y. ;
Rahav, G. .
CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 (01) :54-60
[6]   Prospective Observational Study of the Impact of VIM-1 Metallo-β-Lactamase on the Outcome of Patients with Klebsiella pneumoniae Bloodstream Infections [J].
Daikos, George L. ;
Petrikkos, Panayiotis ;
Psichogiou, Mina ;
Kosmidis, Chris ;
Vryonis, Evangelos ;
Skoutelis, Athanasios ;
Georgousi, Kleoniki ;
Tzouvelekis, Leonidas S. ;
Tassios, Panayotis T. ;
Bamia, Christina ;
Petrikkos, George .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (05) :1868-1873
[7]   Impact of Results of a Rapid Staphylococcus aureus Diagnostic Test on Prescribing of Antibiotics for Patients with Clustered Gram-Positive Cocci in Blood Cultures [J].
Davies, Jane ;
Gordon, Claire L. ;
Tong, Steven Y. C. ;
Baird, Robert W. ;
Davis, Joshua S. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2012, 50 (06) :2056-2058
[8]   METAANALYSIS IN CLINICAL-TRIALS [J].
DERSIMONIAN, R ;
LAIRD, N .
CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188
[9]   Rapid Molecular Diagnostics, Antibiotic Treatment Decisions, and Developing Approaches to Inform Empiric Therapy: PRIMERS I and II [J].
Evans, Scott R. ;
Hujer, Andrea M. ;
Jiang, Hongyu ;
Hujer, Kristine M. ;
Hall, Thomas ;
Marzan, Christine ;
Jacobs, Michael R. ;
Sampath, Rangarajan ;
Ecker, David J. ;
Manca, Claudia ;
Chavda, Kalyan ;
Zhang, Pan ;
Fernandez, Helen ;
Chen, Liang ;
Mediavilla, Jose R. ;
Hill, Carol B. ;
Perez, Federico ;
Caliendo, Angela M. ;
Fowler, Vance G., Jr. ;
Chambers, Henry F. ;
Kreiswirth, Barry N. ;
Bonomo, Robert A. .
CLINICAL INFECTIOUS DISEASES, 2016, 62 (02) :181-189
[10]   Deaths Attributable to Carbapenem-Resistant Enterobacteriaceae Infections [J].
Falagas, Matthew E. ;
Tensarli, Giannoula S. ;
Karageorgopoulos, Drosos E. ;
Vardakas, Konstantinos Z. .
EMERGING INFECTIOUS DISEASES, 2014, 20 (07) :1170-1175